SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022

BOSTON and LAUSANNE, Switzerland, Feb 16, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full year 2021 before U.S. markets open on Tuesday, March 15, 2022. SOPHiA will host a conference call and live webcast to discuss its financial results …

SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022 Read More »

SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research

The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources for precision medicine. BOSTON & ALISO VIEJO, Calif., United States and LAUSANNE, Switzerland – March 14, 2022 – SOPHiA GENETICS (Nasdaq: SOPH) and REALM IDx announced today that they signed a letter of intent to collaborate …

SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research Read More »

NEW SPACE ECONOMY MOOC

The EPFL (Ecole Polytechnique de Lausanne) has released today a New Space Economy online course, available on the edX platform, featuring Mathieu Bailly, VP Space at CYSEC, on the topic of cybersecurity for commercial space missions. Everyday we can read in the news about new cyber attacks. But can this happen to commercial space companies? What could be the consequences? What exactly …

NEW SPACE ECONOMY MOOC Read More »

KATA CONTAINERS: THE ULTIMATE WORKLOADS ISOLATION

The EPFL (Ecole Polytechnique de Lausanne) has released today a New Space Economy online course, available on the edX platform, featuring Mathieu Bailly, VP Space at CYSEC, on the topic of cybersecurity for commercial space missions. Everyday we can read in the news about new cyber attacks. But can this happen to commercial space companies? What could be the consequences? What exactly …

KATA CONTAINERS: THE ULTIMATE WORKLOADS ISOLATION Read More »

BOSTON, Mass, United States, LAUSANNE, Switzerland, and TAIPEI CITY, Taiwan – March 9, 2022 –…

BOSTON, Mass, United States, LAUSANNE, Switzerland, and TAIPEI CITY, Taiwan – March 9, 2022 – SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in Taiwan aiming to provide genetic testing to clinicians, is the first institution in Asia Pacific to adopt SOPHiA GENETICS’ technology to support …

BOSTON, Mass, United States, LAUSANNE, Switzerland, and TAIPEI CITY, Taiwan – March 9, 2022 –… Read More »

NetGuardians lance une nouvelle solution pour aider les PME suisses à prévenir les fraudes

Nous avons le plaisir d’annoncer le lancement de notre nouvelle solution de prévention de la fraude aux paiements destinée aux petites et moyennes entreprises suisses. Cette solution innovante est actuellement offerte gratuitement et sans engagement pour une période d’essai de 90 jours. Basée sur le logiciel de prévention de la fraude que NetGuardians a déjà déployé avec succès …

NetGuardians lance une nouvelle solution pour aider les PME suisses à prévenir les fraudes Read More »

STALICLA at the first NDD Summit in 2021

We are very pleased to share the replay of STALICLA’s expert presentation at the first Neurodevelopmental Disorder Drug Development held in December. The first edition of the Neurodevelopmental Disorders Drug Development Summit was organized by Hanson Wade, a healthcare specialized initiative with the goal to accelerate progress within organizations and across industries. Their primary method …

STALICLA at the first NDD Summit in 2021 Read More »

SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies

The SOPHiA DDM HRD Solution offers cost-effective, accurate, reliable, timely, and easily implementable in-house results to empower better clinical research decisions BOSTON, United States and LAUSANNE, Switzerland – FEBRUARY 24, 2022 – SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, announced today the launch of their SOPHiA DDM Homologous Recombination Deficiency (HRD) Solution, opening new doors for …

SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies Read More »